Literature DB >> 15218204

Diabetic heel ulcers: a major risk factor for lower extremity amputation.

Nidal A Younes1, Abla M Albsoul, Hamzeh Awad.   

Abstract

Of all the ulcers seen in patients with diabetes, heel ulcers are the most serious and often lead to below-the-knee amputation. Management of heel ulcers requires a thorough knowledge of the major risk factors for ulceration in the heel area and a standardized program of local ulcer care, metabolic control, early control of infection, and improvement of blood supply to the foot. The most common risk factors for ulceration in the heel region include immobility of the lower limbs, diabetic neuropathy, structural deformity, and peripheral arterial occlusive disease. Patient education regarding foot hygiene, skin care, and proper footwear is crucial to reducing the risk of an injury that can lead to heel ulceration. A careful foot examination that tests for neuropathy and arterial insufficiency can identify patients at risk for heel ulcers and appropriately classify patients with ulcers into different grades to design proper therapeutic plans for management. Team management programs that focus on education, prevention, regular foot examinations, aggressive intervention, and proper use of therapeutic measures can significantly reduce the risk of lower-extremity amputations from heel ulcers.

Entities:  

Mesh:

Year:  2004        PMID: 15218204

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  11 in total

1.  Multimodal therapy as an algorithm to limb salvage in diabetic patients with large heel ulcers.

Authors:  Ewan B Goudie; Cynthia Gendics; John C Lantis
Journal:  Int Wound J       Date:  2011-09-23       Impact factor: 3.315

2.  Heel ulcers do heal in patients with diabetes.

Authors:  Hedvig Örneholm; Jan Apelqvist; Jan Larsson; Magnus Eneroth
Journal:  Int Wound J       Date:  2016-08-04       Impact factor: 3.315

3.  Diabetes mellitus in individuals with spinal cord injury or disorder.

Authors:  Sherri L Lavela; Frances M Weaver; Barry Goldstein; Ke Chen; Scott Miskevics; Suparna Rajan; David R Gater
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

Review 4.  Slow to heel: a literature review on the management of diabetic calcaneal ulceration.

Authors:  Rachel Khoo; Shirley Jansen
Journal:  Int Wound J       Date:  2018-02-12       Impact factor: 3.315

5.  Medium-term outcomes of multi-disciplinary surgical management of non-ischemic diabetic heel ulcers.

Authors:  Ngwe Phyo; Wegin Tang; Venu Kavarthapu
Journal:  J Clin Orthop Trauma       Date:  2021-01-30

6.  Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report.

Authors:  Fátima Alvarez Reyes; Cristina Luna Gómez; Manuel Brito Suárez
Journal:  J Med Case Rep       Date:  2011-04-16

7.  A Novel and Alternative Treatment Method for Diabetic Heel Ulceration Exposing the Calcaneus Which Is Not Suitable for Flap Surgery: Vacuum Assisted Sandwich Dermal Matrix.

Authors:  Ugur A Bingol; Can Cinar; Hakan Arslan; Muzaffer Altındas
Journal:  Biomed Res Int       Date:  2015-09-21       Impact factor: 3.411

8.  A study of prognostic factors in Chinese patients with diabetic foot ulcers.

Authors:  Aiping Wang; Xinjuan Sun; Wei Wang; Kechun Jiang
Journal:  Diabet Foot Ankle       Date:  2014-03-11

Review 9.  Growth factors for treating diabetic foot ulcers.

Authors:  Arturo J Martí-Carvajal; Christian Gluud; Susana Nicola; Daniel Simancas-Racines; Ludovic Reveiz; Patricio Oliva; Jorge Cedeño-Taborda
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28

10.  Heal or no heel: Outcomes of ischaemic heel ulcers following lower limb revascularization from a multi-ethnic Asian Cohort in Singapore.

Authors:  Yun Le Linn; Sze Ling Chan; Shereen Xue Yun Soon; Charyl Jia Qi Yap; Mervin Nathan Han Hui Lim; Qing Wei Shaun Lee; Tze Tec Chong; Tjun Yip Tang
Journal:  Int Wound J       Date:  2020-08-24       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.